| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_399f43c51e40666f21a884409259b9e9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10041 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2019-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c305ded3a13118496f49538a6ee6cf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d18740b4569f9d9d35a8834448320c32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d8c24ca228af0a43855e744c790a38a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f3db82a79b6fbb988e85bd4dcd24df4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7124a267b724038b0dff2dbf886bf937
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be0c3ef8468824560623bd496c3af6b1 |
| publicationDate |
2019-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102059855-B1 |
| titleOfInvention |
Recombinant adenovirus strain and vaccine composition against vivax malaria using the same |
| abstract |
The present invention relates to a recombinant adenovirus strain comprising a 33 kDa fragment gene of cleavage surface protein-1 (MSP-1) of Plasmodium vivax , a vaccine composition for preventing triplet malaria infection using the same, and a method for preparing the same. It is about. The present invention also provides a prime-boost combination vaccine composition comprising a recombinant adenovirus line based vaccine composition and a recombinant vaccinia virus line based vaccine composition. |
| priorityDate |
2019-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |